Mutual of America Capital Management LLC Buys New Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Mutual of America Capital Management LLC acquired a new stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 2,287 shares of the company’s stock, valued at approximately $203,000.

Other hedge funds have also recently bought and sold shares of the company. Venturi Wealth Management LLC grew its stake in U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after purchasing an additional 704 shares in the last quarter. KBC Group NV grew its stake in U.S. Physical Therapy by 68.6% during the 3rd quarter. KBC Group NV now owns 774 shares of the company’s stock valued at $66,000 after purchasing an additional 315 shares in the last quarter. Pacer Advisors Inc. acquired a new stake in U.S. Physical Therapy during the 4th quarter valued at approximately $113,000. First Horizon Advisors Inc. grew its stake in U.S. Physical Therapy by 25.1% during the 3rd quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company’s stock valued at $126,000 after purchasing an additional 298 shares in the last quarter. Finally, Sugar Maple Asset Management LLC acquired a new stake in U.S. Physical Therapy during the 3rd quarter valued at approximately $212,000.

U.S. Physical Therapy Trading Down 1.2 %

Shares of NYSE USPH opened at $79.87 on Tuesday. The company has a market cap of $1.21 billion, a price-to-earnings ratio of 84.96, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51. U.S. Physical Therapy, Inc. has a 12-month low of $76.18 and a 12-month high of $113.63. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The stock’s 50 day simple moving average is $87.21 and its 200 day simple moving average is $87.56.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. Equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be given a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.25%. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy’s payout ratio is 97.83%.

Insiders Place Their Bets

In related news, COO Graham D. Reeve sold 1,730 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at $588,564.48. The trade was a 19.44 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.70% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on USPH shares. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. William Blair reiterated a “market perform” rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. Barrington Research decreased their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. Finally, JMP Securities started coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They issued an “outperform” rating and a $113.00 target price for the company. One research analyst has rated the stock with a sell rating, one has given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, U.S. Physical Therapy has a consensus rating of “Moderate Buy” and an average target price of $111.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.